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ABSTRACT
UNDERSTANDING THE ROLE OF REACTIONS TO RACE-BASED TREATMENT ON
HIV TESTING BEHAVIORS
By
JOËLLE FOLSADÉ ATERE-ROBERTS
May 4, 2016

INTRODUCTION: In the United States, Blacks and Hispanics compared to Whites are
disproportionately infected with HIV. Testing for HIV is critical to reduce HIV
transmission, lower risk behaviors, and improve access to treatment among persons
living with HIV. However, racial & ethnic minorities are tested at later stages of HIV.
Previous studies that examined racial discrimination and HIV testing reported
inconsistent findings and additional knowledge is needed to understand whether
differential treatment based on race is an important barrier to HIV testing.
AIM: We examined whether HIV testing is influenced by how an individual reacts to
race-based treatment, rather than experiences of discrimination alone, among Whites,
Blacks, and Hispanics; and we determined if this relationship was modified race and
ethnicity.
METHODS: We performed a cross-sectional analysis of the 2012 Behavioral Risk
Factor Surveillance System’s (n=12,579) self-reported HIV testing data and Reaction to
Race (RR) module, which captures experiences of differential treatment based on race
and an individual’s reaction to racialized treatment. Multivariable logistic regression was
used to assess the association between RR-based treatment and HIV testing. Statistical
interaction between RR-based treatment and race was assessed.
RESULTS: Approximately 21% participants reported ever being tested for HIV, and
19% of the participants had one or more experiences of RR-based treatment.
Prevalence of HIV testing was higher among Blacks (62%) and Hispanics (33%)
compared to Whites (32%). In an adjusted model, the odds of HIV testing among those
who reported one experience of Reactions to Race based treatment was 1.37 (95% CI:
1.08-1.75) times the odds among those with no experiences of RR-based treatment. We
did not detect statistical interaction between RR-based treatment and HIV testing by
race.
DISCUSSION: Our findings suggest that experiences of racial discrimination may be
counter intuitively associated with increased HIV testing overall and within each racial
and ethnic group. Additional research is needed to clarify settings in which experiences
of race-based treatment and the associated reactions to the treatment can positively or
negatively influence HIV testing behaviors.
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Chapter I- Introduction
This thesis seeks to understand racial and ethnic disparities in HIV infection by
examining the potential pathway through which experiences of racial discrimination can
influence HIV testing behaviors. In the United States, Blacks and Hispanics are
disproportionately infected with HIV compared to Whites.1 Moreover, Blacks (15%) and
Hispanics (15%) have the highest percentage of undiagnosed HIV infections compared to
Whites (11%).2 Existing research recognizes the critical role HIV testing plays in preventing HIV
transmission through initiation of HIV treatment and reducing high-risk sexual and drug use
behaviors among those who are HIV infected.3 Therefore, an understanding of HIV testing
behaviors among Blacks and Hispanics compared to Whites is crucial to understanding
persistent racial and ethnic disparities in HIV.
While research has found that HIV testing rates are higher among Blacks and Hispanics
compared to Whites,4 a high percentage of Blacks (38%) and Hispanics (52%) report that they
have never been tested for HIV in their lifetime compared to Whites (59%)5 This suggests a
continued need for improving HIV testing and prevention efforts among racial and ethnic
minorities. Existing research has suggested that HIV testing barriers, for example fear of
positive HIV status, lack of access to care, and misconceptions about HIV risk, may influence
racial and ethnic disparities in HIV.6-9
A separate but growing body of literature has also indicated that racial discrimination,
defined as differential treatment based on phenotypic race, may be an important predictor of
HIV testing and racial and ethnic disparities in HIV. Racial discrimination is associated with a
host of poor health outcomes and behaviors, which may partially account for many racial and
ethnic health disparities. 10-13 For example, experiences of racial discrimination among
marginalized groups has been associated with elevated blood pressure, negative mental health
outcomes, and increased smoking behavior.6-9 In the case of HIV testing, racial discrimination
1

results in a unique set of stressors among minorities, which triggers a response to racial stimuli
that may negatively impact HIV testing behavior. High levels of stress are positively related to
high-risk coping behaviors including sex and drug use and are negatively related to healthy
behaviors including breast and prostate cancer screening.11,14-17 The pathways by which racial
discrimination can affect HIV testing may require different operationalization of racial
discrimination, which would result in variability in how racial discrimination is measured.
A small body of literature on the relationship between racial discrimination and HIV
testing, has counter intuitively shown a positive relationship where experiences of discrimination
are associated with higher rates of HIV testing. However, the variability between the results of
this existing literature is likely due to differences in the operationalization of discrimination.
Different measures have been used to capture perceived acute experiences of discrimination,
chronic experiences, and some literature with no clear distinction between the type(s) of
discrimination being measured (Table I) 18.
Since studies have examined the association between experiences of racial
discrimination and HIV testing, we address gaps in the literature by examining this relationship
in a racially diverse sample. Given the mixed results of previous studies on racial discrimination
& HIV testing, this research is critical in understanding the pathways by which racial
discrimination can be detrimental or constructive in regard to seeking HIV testing. This research
adds to the literature by examining not only the experience of racial discrimination, but also the
individuals’ reactions to the differential treatment based on race. Herein, we examined the
association between Reactions to Race-based treatment and HIV testing behaviors within racial
and ethnic groups; and we hypothesized that respondents who report Reactions to Race-based
treatment have lower HIV testing prevalence and an interaction between race and ethnicity and
Reactions to Race-based treatment with respect to HIV testing will be present. This thesis uses
the Reactions to Race module measures, which captures 1) whether or not an individual
2

experiences racial discrimination, 2) whether an individual embodies the experiences, and 3)
how an individual responds to race-based treatment.19 In essence, the Reactions to Race scale
captures an individual’s experience of differential treatment based on race and whether or not
an individual perceives that they experience a physical or emotional response to a racialized
experience. Reactions to Race based treatment have been shown to be negatively related to
poor self-rated health, lower breast cancer screening, lower colorectal cancer screening by
endoscopy and digital rectal exam.20-22The next chapters delve into the existing literatures that
assess HIV testing and health disparities, barriers to HIV testing, discrimination pathways on
health behaviors, and the relationship between racial discrimination and HIV testing. Following
the literature review, we will present the methods and findings of the proposed research
question.
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Chapter II-Literature Review
2.1 The role of HIV testing in reducing racial and ethnic disparities in HIV.
Racial and ethnic disparities in HIV transmission are pervasive in the US.23 Blacks
accounted for 47% of incident HIV infections and an estimated 43% of prevalent HIV infections
in 2012. Additionally, Hispanics represented 16% of the US population in 2012 but accounted
for over one-fifth (21%) of the new HIV infections and 19% of individuals living with HIV.1
National estimates have found that of approximately 1.2 million people living with HIV infection
in the United States, about 12.8%, most of whom are Black and Hispanic, are unaware of their
HIV status.24 Specifically, 17% of Blacks and 17% of Hispanics compared to only 13% of Whites
(13%) have undiagnosed HIV infections.2 Knowledge of HIV status is particularly important in
reducing HIV transmission as previous studies have shown that knowledge of HIV status is
associated with fewer high-risk behaviors, which would lower the risk for acquiring and/or
transmitting HIV.25,26 Individuals who are HIV-positive have increased rates of condom use
during sex, lower rates of injection drug use, and decreased rates of sex in exchange for money
after becoming aware of their HIV status.27-30 Knowledge of HIV status is also important
because, once an individual is diagnosed as HIV positive s/he can be linked to care and medical
services that can reduce morbidity, mortality and improve quality of life.31, Given this, HIV
testing is a crucial part of HIV prevention, treatment, and care.32
Although studies show that HIV testing rates are higher among Blacks (59.7%) and
Latinos (45.6%) compared to Whites (42.4%)5, other data indicate important gaps in HIV testing
among racial and ethnic minorities. For example, racial and ethnic minorities are more likely to
be tested in later stages of infection and die from AIDS compared to whites.4 Among those with
HIV, 31% of Blacks and 36% of Hispanics compared to 32% of whites were tested in the late
stages of illness, which is measured by being diagnosed with AIDS within one year of testing
HIV positive.33 This suggests an important gap in our understanding and ability to reach and test
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racial and ethnic minorities who are farther along in the progression of HIV.34 Murray and Oraka
conducted a study using data from the National Health Interview Survey to understand HIV
testing intentions by race and ethnicity.35 The results revealed Whites (81%) and Asians (71%)
had a significantly higher percentage of individuals who were never tested for HIV because they
perceived themselves to be at low risk compared to Blacks (66%) and Hispanics (65%). On the
other hand, Blacks and Hispanics had higher percentages of respondents who never received a
HIV test due to fear of HIV-related stigma compared to other races. The results of this study
gives insight on the varying levels of perceived risk of infection across racial and ethnic groups,
which may be important to understand decisions to not be tested for some racial and ethnic
minorities.
There are a number of ways that higher rates of HIV testing among racial and ethnic
minorities might reduce high-risk behaviors to prevent transmission of the virus to others. First,
those who test HIV positive and initiate antiretroviral treatment (ART) to achieve a suppressed
viral load will have a lower likelihood of transmitting HIV to others.36 Furthermore, an individual
who tests positive for HIV can identify other sexual partners who are at risk and recommend HIV
testing and/or encourage the use of pre-exposure prophylaxis to decrease their chance of
getting infected.37 Therefore, we should consider HIV testing not only as a diagnostic tool but
also as an important HIV prevention strategy that could be important to reducing inequities in
HIV by race and ethnicity.

2.2 Barriers to HIV testing among racial and ethnic minorities
The Centers for Disease Control and Prevention (CDC) recommends that adolescents
and adults age 13-64 get tested for HIV at least once as a routine part of medical care, and
even more frequent testing among men who have sex with men and other populations who
engage in high risk behavior such as injection drug use and unprotected sex.34 Although the
rates of HIV testing have increased, approximately 55% of Americans have not been tested in
5

their lifetime.38 Fear of a positive HIV diagnosis, misconceptions about HIV risk and HIV testing
procedures, and lack of access to healthcare are key barriers to increasing HIV testing.38 In a
study on barriers to HIV testing among Hispanics, Lopez-Quintero et al found 75% of
participants reported “not considering oneself to be at risk” as the primary reasons for not
getting tested.39 However, the study did not consider other social factors such as access to
healthcare, discrimination, socioeconomic status etc. that could also influence respondents’
reason for not being tested. In another study using data from the Web-based HIV Behavioral
Surveillance (WHBS), MacKeller et al. show Black (37%) and Hispanic (21%) MSM reported
fear of testing positive as a primary reason for not testing at higher rates compared to Whites
(15%).40 Bond et al. further examined the structural as well as individual-level barriers to HIV
testing, and the authors found that structural-level measures including having a regular
healthcare provider and the number of visits to the doctors were important correlates of HIV
testing.41
Another important factor that may influence HIV testing may be physician
recommendation. For example, a number of studies have shown that racial and ethnic
minorities are less likely to be offered preventive, operative and other services in the healthcare
setting. Specifically, in their study on socially assigned race and healthcare discrimination,
MacIntosh et al. found that racial and ethnic minorities who were perceived socially as white
were more likely to receive preventive vaccinations and less likely to report perceived
healthcare discrimination.42 So, it is possible that individuals who perceive differential treatment
in a healthcare setting are less likely to receive important screening tests because of physician
failure to offer and encourage testing.

2.3 Pathway for racial discrimination influencing health
Jones defines racial discrimination as “differential actions towards others by race that
can influence health”.43 The research literature suggests that racial discrimination can influence
6

health through multiple pathways. Most discrimination research has focused on the
psychosocial pathway, which posits that discrimination is a stressor that affects the
neuroendocrine, autonomic, and immune systems.44 Changes in various biological systems
leads to physiological changes that influence cellular decay.44 Individuals also often engage in
high-risk coping behaviors that relieve stress but also put them at risk for poor health. Most of
the research along this pathway has shown a positive relationship between racial discrimination,
poor mental and physical health outcomes and negative health behaviors.10 11-13 Specifically,
discrimination is related to elevated blood pressure,6,7 higher levels of depression,8 increased
smoking behaviors,9 and increased alcohol use.45
Another pathway through which discrimination has been posited to affect health is
through access to individual and macro-level resources.11 On the individual level, Crawford et al
argues that discrimination can lead to more high-risk social relationships that influence disease
transmission and fewer health promoting social relationships that would advocate for healthier
behaviors.46 On the macro level, a very large body of literature has examined discrimination
through an institutional lens whereby policies and community efforts segregate minorities from
healthy residential environments.16,47,48 Williams defines racial residential segregation as “the
physical separation of races by enforced residence in certain areas.”47. Racially segregated
neighborhoods have been shown to have inadequate education, fewer recreational facilities,
higher levels environmental hazards, fewer jobs, and limited access to medical care, which
restrict the residents’ ability to practice effective heath behaviors and result in negative health
consequences among marginalized racial groups.47 While we believe all of the pathways of
discrimination are important and may have an influence on HIV testing behavior, this thesis
argues that racial discrimination acts as a psychosocial stressor, which affects health, and
results in coping behaviors that are negatively associated with HIV testing.
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2.4 Racial Discrimination and HIV Testing Behavior
While theoretical frameworks of discrimination-health relationships18 suggests that
discrimination may influence HIV testing behavior, research examining the influence of racial
discrimination on HIV testing behaviors is mixed.10 Irvin et al. examined the relationship
between healthcare-specific racial discrimination and HIV testing among black men who have
sex with men (MSM).49 Over 80% of participants who reported healthcare-specific discrimination
had been tested for HIV within the last year and healthcare-specific racial discrimination was
positively associated with HIV testing [OR=1.6 (95% confidence interval: 1.1, 2.4)]. In this study,
healthcare specific racial discrimination was operationalized as unfair treatment due to race for
the participant, a friend, family member, or someone they knew. Therefore, healthcare specific
discrimination may have overestimated individual experiences of discrimination, which would
positively bias the exposure estimate resulting in an attenuated relationship between
discrimination and HIV testing. Furthermore, the measure included all healthcare-specific
discrimination experiences over the lifetime and therefore the temporal relationship between
discrimination and HIV testing could not be assessed. In another clinic-based study, Ford et al.
examined the association between perceived everyday racism and HIV testing behavior among
373 Blacks seeking sexually transmitted disease (STD) testing in the deep South. This study
showed that more than 90% of participants perceived everyday racism, which was associated
with higher odds of receiving an HIV test [OR=1.64 (1.07,2.52)] .10 Since this study was limited
to a sample of Blacks, the relative difference in HIV testing with other racial and ethnic groups is
unclear. Moreover, this study operationalized discrimination using the everyday discrimination
scale, which captures chronic, routine, and relatively minor experiences of racial discrimination.8
The items on the scale capture the day-to-day experiences of discrimination including
differential treatment compared to others, being treated with less respect than others, receiving
poorer quality service than others, viewed as not smart, viewed as dishonest, viewed as less
than, called names/insulted, and being threatened or harassed.(Table I).8 While Krieger et al.
8

showed that the everyday racism scale has strong validity and reliability11, it is possible that
experiences of racial discrimination in and of itself are not linked to HIV testing because it is not
these everyday experiences that affect behaviors, but an individuals’ response and ability to
recover from these negative experiences in order to maintain a healthy state. In other words, if
an individual has a racialized experience that they are unaware of or they are able to cope with
the experience to “move on,” we might not expect this to affect their health. On the other hand, if
an individual has a racialized experience that causes them emotional or even physical strain
and they have difficulty “moving on” from a negative experience, we would expect this
rumination and perseverative cognition to affect their health.
Given that few studies have examined the relationship between discrimination and HIV
testing, but a small piece of evidence counter intuitively suggests a positive relationship where
experiences of discrimination predict higher HIV testing uptake, we will examine how reactions
to race-based treatment affect HIV testing behaviors. This examination adds to the existing
literature by 1) examining how an individuals’ response to racial discrimination, not just an
experience of racial discrimination alone, measured by the Reactions to Race module
influences HIV testing behavior and 2) assessing this research question in a racially diverse
sample for which we will be able to understand differences in experiences of reactions to racial
discrimination and its relationship to HIV among non-Hispanic Whites, non-Hispanic Blacks and
Hispanics.
2.5 Reactions to Race-based treatment and HIV testing
The Reactions to Race module captures personal experience and how an individual
responded to differential treatment because of their race. This module has undergone several
rounds of cognitive testing, field-testing, and pilot testing when it was launched by the CDC in
2002. Since being piloted, the six measures in the module have been operationalized
individually and in combination with each other to assess the impact of race-based treatment on
9

various health behaviors and health outcomes.20,22,50 Reliability and validity testing of the
Reactions to Race based measures reveal that the module had adequate face validity, but may
be limited in its reliability because this measure has not been replicated in another sample.19,22
In this analysis, we examine the association between Reactions to Race-based
treatment and HIV testing behaviors among non-Hispanic White, non-Hispanic Black, and
Hispanic individuals; and examine if the association between Reactions to Race-based
treatment and HIV testing is modified by race/ethnicity using data from the 2012 Behavioral Risk
Factor Surveillance System (BRFSS). We hypothesized that non-Hispanic White, non-Hispanic
Black, and Hispanics who report Reactions to Race-based treatment would have significantly
lower HIV testing prevalence and heterogeneity of effect between race and ethnicity and
Reactions to Race-based treatment with respect to HIV testing will be present. Specifically,
Non-Hispanic Blacks and Hispanic individuals who report Reactions to Race-based treatment
will have a significantly lower HIV testing prevalence compared to non-Hispanic Whites.
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Chapter III-Manuscript
INTRODUCTION
Racial and ethnic disparities in HIV transmission, infection, and treatment are pervasive.
In the United States, Blacks and Hispanics are disproportionately infected with HIV compared to
Whites and have the highest percentage of undiagnosed HIV infections.1,2 Specifically, 15% of
Blacks and 15% of Hispanics have the undiagnosed HIV infections compared to 11% of
Whites.2 HIV testing plays a critical role in preventing HIV transmission, as individuals with HIV
who know they are positive are more likely to initiate HIV treatment and less likely to participate
in high-risk sexual or drug use behaviors.3 Although HIV testing rates are higher among Blacks
and Hispanics compared to Whites, 17% of Blacks and 17% of Hispanics compared to 13% of
Whites are unaware of their HIV status.2 This suggests a continued need for improving HIV
testing and prevention efforts among Black and Hispanic communities.4
Previous studies have described barriers to HIV testing.38,51 The most commonly cited
barriers to HIV testing that may influence racial and ethnic disparities in HIV include HIV
exceptionalism or the fear of a HIV positive status being different from other diseases, lack of
access to care, and misconceptions about HIV risk.8 40,51,52 Research has also suggested that
racial discrimination may be an important factor that influences decisions to engage in positive
health behaviors as well as opportunities to receive health-promoting resources such as
screening tests.8,11,15,22 Racial discrimination acts as a system of differential treatment based on
phenotypic race which structures opportunities and resources that influence health and health
behaviors.19 The discrimination literature has implicated racial discrimination as a fundamental
determinant of racial and ethnic inequities in health,19 Racial discrimination incites physiological
stressors as a response to racialized experiences that increases negative coping behaviors that
might put one at risk for HIV transmission while decreasing positive health behaviors such as
HIV testing.16 Previous literature has used various measures to capture racial discrimination, but
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many of these measures do not capture whether or not an individual perceives these
experiences as problematic. This study measures racial discrimination using the Reactions to
Race module of the Behavioral Risk Factor Surveillance System (BRFSS) which captures an
individual’s experience of differential treatment based on race and whether or not an individual
perceives that they experience a physical or emotional response to a racialized experience.
Given the pervasiveness of discrimination in the United States,19 it is possible that individuals
who experience discrimination are primed for these negative encounters and thus they have no
effect on the individual psychologically or physiologically.53 Given this, we examined the
relationship between racial discrimination and HIV testing behaviors using the Reactions to
Race module, which measures an individuals’ response to racial discrimination, rather than just
an experience of racial discrimination alone. We also determined whether any relationship
between Reactions to Race-based treatment and HIV testing is differential by Whites, Blacks,
and Hispanic participants in the Behavioral Risk Surveillance Survey (BRFSS). We
hypothesized that Whites, Blacks, and Hispanics who reported Reactions to Race-based
treatment would have lower HIV testing prevalence and heterogeneity of effect between race
and ethnicity and Reactions to Race-based treatment with respect to HIV testing will be present.
Specifically, Blacks and Hispanic individuals who report Reactions to Race-based treatment will
have a significantly lower HIV testing prevalence compared to Whites.

METHODS
Data Source
The BRFSS is a nationally representative, state-level, random-digit dialed telephone,
multistage-cluster sampling survey administered by the Centers of Disease Control and
Prevention (CDC). A detailed account of the study procedures, sampling and instruments have
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been described elsewhere.54 But, in brief, the survey collects data on non-institutionalized, adult
(≥18 years) residents in the United States.55 BRFSS includes three sections to ascertain
information on health-related risk behaviors, chronic health conditions and use of preventive
services: the core section, optional modules, and additional questions from each state. We used
the 2012 survey, when the Reactions to Race module was administered as an optional module
to capture the experience of differential treatment based on race in a population-based sample
of Arizona and Wyoming.
Sample Population
The sample population included non-Hispanic Whites (n=11,007), non-Hispanic Blacks
(n=146), and Hispanics (n=1388) aged ≥ 18 years who responded to at least one of the
questions in the Reactions to Race module. In 2012, 13,579 participants aged ≥18 in Arizona
(n=7,306) and Wyoming (n=6,273) responded to the survey. Due to small sample sizes,
participants who identified as Asian, Native Hawaiian or other Pacific Islander, American Indian
or Alaska native, or some Other race or Multiracial were excluded from this analysis (n=600).
Outcome – HIV testing
HIV testing was assessed via self-report through a question on the BRFSS core
questionnaire. Participants were asked, “Have you ever been tested for HIV?” Available
responses were yes, no, don’t know, and refused. For this analysis, we only included those who
reported yes or no.
Exposure – Reactions to Race
Six questions were administered on the Reactions to Race optional module to assess
personal experiences of differential treatment based on race and the Reactions to Race-based
treatment. We investigated four of the six measures. The questions and responses include:
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1. Race Consciousness: “How often do you think about your race? Would you say never,
once a year, once a month, once a week, once a day, once an hour, or constantly?”
2. Healthcare treatment: “Within the past 12 months when seeking health care, do you feel
your experiences were worse than, the same as, or better than for people of other
races?” Individuals who responded that they only encountered people of the same race
and did not seek healthcare within the past 12 months were excluded from the entire
analysis.
3. Physical symptoms: “Within the past 30 days, have you experienced any physical
symptoms, for example, a headache, and upset stomach, tensing of your muscles or a
pounding heart, as a result of how you were treated based on your race?” Possible
response categories included yes, no, and don’t know/not sure.
4. Emotional symptoms: “Within the past 30 days, have you felt emotionally upset, for
example angry, sad, or frustrated, as a result of how you were treated based on your
race?” Possible response categories included yes, no, and don’t know/not sure.
We assessed the association between each of the four questions separately with the
outcome (ever tested for HIV). Responses for race consciousness were recoded as always
(constantly, once an hour, or once a day), sometimes (once a week or once a month), never
(once a year or never) and don’t know. For the healthcare treatment responses, worse than
other races/better than others was included in the worse than other races category. Emotional
and physical symptoms due to race-based treatment were analyzed as collected. In addition to
assessing each question independently, we also created a composite score of all experiences
of race-based treatment and responses using all four questions based on previous studies in
the literature.21 The Reactions to Race composite score was categorized into three categories:
1) no experiences of reactions to race based treatment (respondents who never thought about
race, experienced equal or better treatment at work & healthcare, and experienced no emotional
nor physical symptoms); 2) one experience of reactions to race based treatment (respondents
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who reported ≥1 of the following: thinking about their race sometime or always, experiencing
worse healthcare or work treatment, even if the respondent felt treatment was better than some,
or experiencing emotional or physical symptoms); and 3) ≥2 experiences of Reactions to Race
based treatment (respondents reporting ≥2 affirmative responses to any of the five Reactions to
Race based treatment measures: thinking about race, experienced worse healthcare treatment,
experienced worse work treatment, suffered emotional symptoms or physical symptoms). Those
who responded “don’t know/not sure” to all Reactions to Race measures were categorized
separately as “unknown number of experiences”.
Potential confounders
Consistent with previous literature, the following characteristics were included in the
analysis as potential confounders of the association between HIV testing behaviors and
Reactions to Race measures: age, sex, marital status, education, income, employment, health
insurance, and high risk behaviors.10,22 Age was grouped into four categories: 18-39, 40-49, 5064, and ≥ 65. Sex was analyzed as collected in the survey (male and female). Marital status
was categorized as married/ member of unmarried couple, divorced/ separated/widowed, and
single. Educational attainment was recoded as less than or equal to high school, high school or
GED, and college or more. Income level was recoded as earning less than $35,000, $35,000$75,000, and greater $75,000 per year. Employment status was classified as employed,
unemployed, and retired. Health insurance was categorized as yes or no. HIV risk was
assessed in the BRFSS by asking respondents if any of the following high risk situations apply
to them: used intravenous drugs, treated for a sexually transmitted or venereal disease, given or
received money or drugs in exchange for sex, or had anal sex without a condom in the past
year. Respondents were not asked about each of these risk behaviors individually.
Effect modifier
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Race/ethnicity was included in the analysis as a potential effect modifier in the
relationship between Reactions to Race based treatment and HIV testing. Race/ethnicity was
classified as mutually exclusive categories including non-Hispanic White, non-Hispanic Black,
and Hispanic. For our analysis, all respondents who identified as White or Black (AfricanAmerican) were Non-Hispanic. Respondents who identified as Hispanic could be of any race
and were classified as Hispanic regardless.
Statistical Analysis
We assessed the bivariate association between Reaction to Race-based measures and
HIV testing using chi-square analysis. For AIM I, descriptive characteristics including frequency
percentages and standard errors56 for categorical variables were calculated for the entire
population. We then calculated the prevalence of HIV testing overall for selected characteristics
and the Reactions to Race measures. In the bivariate analysis, we performed chi-square tests
to assess the unadjusted relationship between select characteristics with HIV testing and the
Reactions to Race composite score. For inclusion in the adjusted model, we considered
statistically significant characteristics (P< .05) in addition to the characteristics that could be
acting as confounders in the casual pathway between experiences of racial discrimination and
HIV testing. For AIM II, descriptive statistics for selected characteristics were calculated, and the
prevalence of HIV testing by race and ethnicity was calculated for selected characteristics.
Multivariable logistic regression model was used to calculate the odds ratios and 95%
confidence intervals between Reactions to Race measures and HIV testing behavior after
adjusting for significant characteristics identified in the bivariate analysis. Interaction terms
between each reaction to race-based treatment measure with race and ethnicity were assessed
to determine heterogeneity of effect. The significance of the statistical interaction terms was
assessed at an alpha level of 0.05. We stratified the adjusted relationship between Reactions to
Race and HIV testing by race and ethnicity to show the effect of Reactions to Race on HIV
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testing within each racial and ethnic group after adjusting for confounders. All analyses were
performed using SAS 9.3. To account for the complex survey design, the analysis was weighted
using procedures in SAS procedures PROC SURVEYLOGISITC, PROC SURVEYMEANS AND
PROC SURVEYFREQ, which account for dependencies between observations.

RESULTS
Descriptive characteristics of all respondents of the Reactions to Race module are
shown in Table II. Overall, most participants in the sample were over 65 (40%), female (59%),
White (88%), married (58%), lived in Arizona (53%), had at least a high school education (35%),
earned less than $35,000 per year (36%), were employed (45%), had health insurance (88%),
and had no HIV risk (93%), and reported no experiences of Reactions to Race based-treatment
(53%). About 21% reported ever being tested for HIV, and 18.9% of the population had one or
more experiences of Reaction to Race based-treatment (Table 2).
Overall the prevalence of the Reactions to Race at least one experience of racial
discrimination was higher among 18-39 (44%) compared to those over 65 (p=<.0001), those
who were married (63%) compared to single (p=<.0001), those who had health insurance (88%)
compared to the uninsured, and those who had no HIV risk (93%) compared to those with HIV
risk (Table 2). The prevalence of HIV testing was significantly higher among participants age
18-39 (50%) compared to those aged 65 and older (p=<.0001), those with health insurance
(78%) compared to those without insurance (p=0.132), those who were employed (60%)
compared to those who were unemployed (p= <.0001), those with no HIV risk (92%) compared
to those with HIV risk (p=<.0001) , and those with some college experience (37%) compared to
those with college or more (p=0.038). (Table 3). There were no significant differences in HIV
testing by participant gender, health insurance status, emotional or physical symptoms from
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racialized experiences. Significantly more participants who received HIV testing had 1 or more
experience of Reactions to Race based-treatment (p=0.004) compared to those who had
In the adjusted analysis (Table 4), we used the Reactions to Race composite score to
calculate the odds of seeking HIV testing for those who had 1 experience of race-based
treatment and 2 or more experiences compared to those who had no experience. One
experience of Reactions to Race based treatment was significantly related to HIV testing
(OR=1.37; 95% CI: 1.08-1.75) and 2 or more experiences (OR=1.37; 95% CI: 0.90-2.08) was
marginally related to HIV testing compared to those who had no experiences of Reactions to
Race-based treatment. Respondents who were Black (OR=2.60; 95% CI: 1.44-4.68) compared
to Whites, those who were divorced, separated, or widowed (OR=1.52; 95% CI: 1.17-2.0)
compared to those who were married or a member of an unmarried couple, those with college
or more education (OR=1.43; 95% CI: 1.09-1.88) compared to less than high school education,
and those with HIV risk (OR=4.31; 95% CI: 2.33-7.97) compared to those with no HIV risk had
an increased odds of HIV testing. Additionally, respondents who reported experiencing physical
symptoms (OR=1.89; 95% CI: 1.12-3.21) compared to no physical symptoms or worse
treatment in the healthcare setting (OR=2.09; 95% CI: 1.09-4.03) as a result of Reactions to
Race based-treatment compared to the same treatment were significantly more likely to report
HIV testing.
With respect to the race-stratified analysis (Table 6), the sample had a majority of
Whites (88%) followed by Hispanics (11%) and Blacks (1%). The prevalence of HIV testing was
higher among Blacks (61.5%) and Hispanics (33.3%) compared to Whites (31.6%) (Pvalue=<.0001; Table 5). The prevalence of 1 or more Reactions to Race based treatment
among those tested for HIV was significantly higher among Blacks (56.2%) and Hispanics
(62.6%) compared to Whites (32.5%). Significant differences in HIV testing by education level,
marital status, health insurance, income, and HIV risk were seen by race and ethnicity.
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Specifically, Hispanics (61%) who had a less than high school education had a higher
prevalence of HIV testing compared to Whites (32%) and Blacks (34%). Compared to Whites
(58%) and Hispanics (53%), Blacks (40%) who were married or a member of an unmarried
couple had a lower prevalence of HIV testing. Among those who had health insurance, Whites
(90%) had the highest prevalence of HIV testing compared to Blacks (81%) and Hispanics
(71%). HIV testing prevalence was significantly lower among Whites (33%) who earned less
than $35,000 per year compared to Blacks (51%) and Hispanics (55%) who earned less than
$35,000. Furthermore, prevalence of HIV testing among Blacks (5%) who had HIV risk was
higher compared to Whites (1%) and Hispanics (3%).
The results of the interaction term testing revealed that no interaction between race and
Reactions to Race-based treatment measures was observed for HIV testing behavior. All
analyses were repeated for each individual Reactions to Race-based treatment measures and
the Reactions to Race composite score.
In the racially stratified adjusted analysis, Whites who had 1 experience of Reactions to
Race based treatment (OR=1.37; CI: 1.07- 2.83) or 2 or more experiences (OR=1.74; CI: 1.061.78) of differential treatment were significantly more likely to seek HIV testing compared to
those who had no experiences. Blacks who experienced Reaction to Race based treatment
were significantly more likely to ever be tested for HIV for measures of Reactions to Race
based-treatment except emotional symptoms compared to Blacks who did not experience the
treatment (Table 6). Specifically, Blacks who had physical symptoms due to race-based
treatment (OR=8.23; CI: 1.58-42.7) were more likely to seek HIV testing compared to those who
had no experiences. Furthermore, Blacks who experienced worse treatment in the healthcare
setting (OR=13.9; CI: 2.06-94.3) compared to those who had the same treatment in healthcare.
Although insignificant Blacks who always thought about their race (OR=2.52; CI: 0.46-13.8)
compared to Blacks who never thought about their race were more likely to be HIV tested. The
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odds of HIV testing among Whites (OR=2.03; CI: 0.61-6.72) and Hispanics (OR=1.00; CI: 0.616.50) were not significantly different for Whites and Hispanics, respectively, who had worse
treatment in the healthcare setting. Hispanics (OR=0.75 CI: 0.82-3.75) and Whites (OR=0.78 CI:
0.35-1.70) who had emotional symptoms due to race based-treatment were insignificantly less
likely to be tested for HIV compared to Hispanics and Whites, respectively, who did not have
emotional symptoms. White (OR=0.73; CI:0.35-1.54) and Hispanic (OR=0.76; CI 0.57-1.79)
respondents who reported better treatment than other races in the healthcare setting were also
insignificantly less likely to get tested for HIV compared to Whites and Hispanics, respectively,
who had the same treatment. The odds of HIV testing among Blacks (OR=2.50; CI: 0.29-21.3)
who had 2 or more experiences of Reactions to Race based treatment was not significantly
higher compared to Blacks who did reported no experiences.

DISCUSSION
The results of this study revealed that experiences of Reactions to Race-based
treatment was associated with increased rates of HIV testing across race and ethnic groups,
and HIV testing behaviors was increased in Whites who experienced race-based treatment
compared to Whites who had no experiences. We hypothesized that measures of Reactions to
Race based treatment was negatively associated with HIV testing prevalence across the total
population, however our findings did not support this hypothesis. The results indicated that
respondents who had an experience of Reactions to Race based-treatment in healthcare,
responded emotionally or physically to differential treatment, or constantly thought about their
race had a higher HIV testing prevalence among the total population. For example, respondents
who experienced worse treatment than other races in the healthcare setting were more likely to
receive HIV testing compared to those who had the same or better treatment.
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In a cross-sectional analysis of BRFSS, Hausmann and colleagues examined the
association between perceived discrimination measured by the Reactions to Race measures
and use of preventive health care services including receiving a flu shot, mammogram, Pap test,
blood stool test, and sigmoidoscopy/colonoscopy.57 In the adjusted model, the results revealed
that utilization of preventive health care services was lower among those who had experiences
of racial discrimination in health care. The findings of our study are inconsistent with
Hausmann’s findings in that that those who had experiences of racial discrimination were more
likely to receive HIV testing.
Although a positive association between Reactions to Race based treatment and HIV
testing appears counterintuitive and does not support theoretical frameworks, other studies
have shown similar findings.49,58 For example, Borrell and colleagues investigated the
association between discrimination with smoking, alcohol consumption, and physical activity.59
In a racially stratified analysis, Blacks who experienced moderate or high racial discrimination
were more physically active than Blacks who reported no discrimination. A possible explanation
could be that racial and ethnic minorities who respond to differential treatment based on race
challenge the negative experience and engage in healthier outcomes and behaviors such as
seeking HIV testing.10 So it is possible that the stressors related to racial discrimination that
result in emotional and/ or physical symptoms could serve as motivation to combat the
differential treatment and in turn seek HIV testing. It is conceivable that Reactions to Race
based treatment is protective of health protective. In the CARDIA study among young Blacks
and Whites, Krieger and colleagues found that Blacks who notice racial discrimination in their
social environment and challenge it could have healthier outcomes than those who do not
engage; therefore perceived racial discrimination may not be inherently detrimental if responses
to those experiences are proactive. 58
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The results of our stratified analysis suggests that there are not differences in
experiences of Reactions to Race based treatment with respect to HIV testing within
racial/ethnic groups. After adjustment for selected covariates, Blacks who had physical
symptoms and had worse healthcare treatment had a higher HIV testing prevalence compared
to Blacks who did not have physical symptoms and the same healthcare treatment, however
these results had unstable odd ratios and 95% confidence intervals likely due to small sample
sizes. Despite the unstable results, this finding is consistent with Ford et al. clinic-based study,
which examined perceiving everyday racism and HIV testing behaviors among Blacks. The
results revealed a higher odds of HIV testing among Blacks who perceived racism compared to
those who did not experience race based treatment.10On the other hand, Blacks who always
thought about their race were more likely to receive HIV testing, however this result was not
statistically significant. On the other hand, Blacks and Hispanics who reported emotional
symptoms due to differential treatment in healthcare were insignificantly less likely to receive
HIV testing. This finding demonstrates the potential negative association between experiences
of racial discrimination and HIV testing.
In another study, Lillie-Blanton and colleagues found that racial and ethnic groups often
experience the healthcare system differently, and racial discrimination acts a barrier to
accessing adequate healthcare services in these communities. Our results were not consistent
with this study. We found the odds of testing for HIV among Blacks who experienced differential
treatment in healthcare were significantly higher compared to those who did not experience
differential treatment. Irvin and colleagues also examined the relationship between healthcarespecific racial discrimination and HIV testing among Black MSM, and found that over 80% of
participants who reported healthcare-specific discrimination had been tested for HIV within the
last year and healthcare-specific racial discrimination was positively associated with HIV testing
[OR=1.6(1.1,2.4)]. Our study is consistent with the findings by Irvin and colleagues although
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these studies operationalized racial discrimination differently. Irvin and colleagues
operationalized healthcare specific racial discrimination as unfair treatment due to race for the
participant, a friend, family member, or someone they knew, compared to our study, which
assessed individual experiences of Reactions to Race based-treatment.
Measurement of racial discrimination is a critically important issue for the future of racial
discrimination assessment.18 There is great variability in how discrimination is assessed, yet no
one measure has been identified as the standard measure. As demonstrated in Table I, the
length, content, and language of the discrimination measures vary for each scale. Therefore,
future research should systematically review existing methodologies used to measure
discrimination to develop a more consistent measure to be used in discrimination literature. This
measure(s) should comprehensively assess discrimination by identifying individual events and
the accumulation of discriminatory events over a lifetime, while also capturing an individual’s
response to differential treatment, Development of a more consistent measure will add to the
discrimination literature by providing a comprehensive measure to better understand of
differential treatment can influence the health of various populations.
Furthermore, the results also revealed that Whites who had 2 or more experiences of
Reactions to Race based treatment were significantly more likely to test for HIV compared to
those who had no experience. It is possible that Whites do not consider notions of culture and
history when thinking about their race; therefore they may associate being discriminated against
with being a marginalized group. In turn, this notion may result in an over or underestimation in
the number of experiences of racial discrimination. This finding suggests that reports of racial
discrimination among Whites specifically need to be further examined. Among Whites, those
who received better treatment than other races in the healthcare setting were less likely to seek
HIV testing compared to those with the same treatment. This finding may be seen because
respondents who are treated better do not believe they are at risk for HIV and in turn seeking
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testing at lower rates. Hispanics who had emotional symptoms due to Reactions to Race based
treatment were less likely to be tested for HIV compared to those who did not experience
emotional symptoms. However, Hispanics who had a physical symptom due to Reactions to
Race based treatment compared to those who did not were more likely to be tested. These
findings suggest that physical and emotional responses to race-based treatment results in
differences in HIV testing behaviors among Hispanics, and underscores the need for additional
research on the manifestation of responses to stress.
The study has several limitations. First, due to the cross-sectional nature of the study,
we are unable to establish temporality. Moreover, because we examine lifetime HIV testing, we
are unable to establish temporality between HIV testing and any of the Reactions to Race
measures. We attempted to assess past year HIV testing (Appendix I), but due to small sample
sizes, we were unable to determine whether Reactions to Race based measures preceded HIV
testing. Second, the self-report nature of the data could result in an overestimation of HIV
testing and over or under-estimation of Reactions to Race based treatment. Third, the statespecific data was weighted to be nationally representative of the given states, it is not
generalizable to all states in the US. Fourth, small sample sizes among the racial and ethnic
minority groups presented a challenge for obtaining stable estimates in the adjusted analyses
among Black and Hispanics.
Despite the limitations, our study had several strengths. Specifically, the sample
population was large enough to include several potential confounders. To our knowledge, this is
the first study to examine the relationship between race based treatment and HIV testing across
races using the Reactions to Race module.
CONCLUSION
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Our study revealed that Reaction to Race based treatment is associated with increased
HIV testing. Further, the odds of HIV testing among those who experienced Reactions to Race
based treatment differed by race and ethnicity. This positive relationships between Reactions
to Race-based treatment and HIV testing is heightened among Black participants who have
expereinced physical symptomscompared to those who did not have physical symptoms and
Whites who had 1 or more experiences of Reactions to Racebased treatment compared to
those who had no expereinces. Understanding whether HIV testing motivations vary by race
and ethnicity is important for understanding differences in HIV. Given that Blacks
counterintuitively were more likely to be tested if they experienced a racialized experience, we
need to better understand the pathways that link discrimination with HIV testing by exploring
whether discriminaiton results in proactive health responses. We must consider the potential
postive association in which stress due to racial discrimination can infleucne an individual’s
health behaviors.To improve inequities in HIV among racial and ethnic minorities, more
research is needed to understand the settings, populations, and outcomes in which Reactions
to Race based treatment is detrimental versus protective.
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Table I. Measures of Racial Discrimination employed in previous literature
Discrimination Survey
Instrument Name
(Author)
The Major and
Everyday
Discrimination Scale
(Williams)

Goal of survey instrument

Two part scale that captures
major experiences of unfair
treatment as well as the chronic,
routine and relatively minor
experiences unfair treatment in
everyday life

Survey Items






Experiences of
Discrimination(EOD)
measure (Krieger)

Reactions to Race
Module (BRFSS)

Perceived Racism
Scale (McNeilly)

Measures the frequency of having
experienced discrimination based
on race, ethnicity, or color and the
individuals’ response to the
experiences



Measures individual experiences
of racial discrimination,
embodiment of the racial
discrimination, and the
individuals’ reaction to race-based
treatment
Multidimensional scale which
measures the frequency of
perceived experiences of racism
among African-Americans and
assesses the emotional and
behavioral coping responses to
racism








Everyday experience of discrimination items:
treated with less courtesy, treated with less
respect, receiving poorer service, viewed as not
smart, viewed as dishonest, viewed as less than,
called names/insulted, and being threatened or
harassed
Major experiences of discrimination: ever unfairly
fired or denied promotion, ever unfairly not hired,
ever unfairly treat by police, ever unfairly
discouraged from continuing education, ever
unfairly prevented from moving, unfairly denied
bank loan, received inadequate services
compared to others
A follow up question is asked to capture the main
reason for the experiences (i.e. gender, race,
age, ancestry, religion etc.)
Ever discriminated against: at school; getting a
job; at work; getting a house; receiving medical
care; interacting with police/courts; or in a public
setting.
Response to unfair treatment: “accept as fact of
life” or “try to do something about it”
How often does the individual think about their
race; experiences of unfair treatment in the
workplace and health care setting, and physical
(e.g. headache, upset stomach, pounding heart)
or emotional (e.g. angry, sad, frustrated)
responses to unfair racial treatment
43 items on the frequency of exposure to racial
discrimination on the job; academic settings;
public settings; racist statements
8 items on emotional responses (e.g. feeling
angry, sad) and behavioral coping responses
(e.g. speaking up, forgetting it, getting violent,
praying) to perceived racism

Table 2. Prevalence of Reactions to Race composite score by sample characteristics and Reaction to Race
measures, Behavioral Risk Factor Surveillance System, Arizona & Wyoming, 2012

ab

2 or more
Unknown
No experience 1 experience experiences experiences
% (SE)
% (SE)
% (SE)
% (SE)
P-value

Total
n =12,541

%

2040
1393
3968
5013

16.4
11.2
32.0
40.4

34 .3 (1.41)
15.7 (1.03)
27.5 (1.12)
22.53 (0.87)

44.4 (2.22)
18.0 (1.68)
23.5 (1.71)
14.0 (1.12)

46.0 (4.78)
21.7 (3.97)
25.7 (3.87)
6.6 (1.58)

65.3 (2.99)
12.7 (2.13)
14.7 (1.89)
7.32 (1.14)

<.0001

Sex
Male
Female

5104
7437

40.7
59.3

44.2 (1.34)
55.9 (1.35)

54.4 (2.15)
45.6 (2.15)

50.3 (4.7)
49.7 (4.7)

56.0 (3.5)
44.0 (3.5)

0.0003

Race
White
Black
Hispanic

11007
146
1388

87.8
1.2
11.1

83.3 (1.28)
2.7 (0.63)
14.0 (1.19)

54.4 (2.23)
4.6 (0.95)
40.9 (2.3)

33.8 (3.9)
11.6 (3.3)
54.5 (4.6)

71.0 (3.6)
4.27 (2.00)
24.7 (3.43)

<.0001

Marital Status
Married/ Member of unmarried couple7108
Divorced/ Separated/Widowed
3974
Single
1312

57.6
31.9
10.5

62.5 (1.3)
20.2 (0.9)
17.3 (1.19)

54.7 (2.2)
18.6 (1.5)
26.7 (2.12)

52.2 (4.7)
14.6 (2.4)
33.2 (4.8)

45.8 (3.4)
14.7 (2.0)
39.5 (3.53)

<.0001

State
Arizona
Wyoming

6584
5957

52.5
47.5

87.6 (0.32)
12.4 (0.32)

95.0 (0.35)
5.00 (0.35)

96.8 (0.60)
3.21 (0.60)

94. 4 (0.72)
5.61 (0.72)

<.0001

Education Level
≤ High School
Some College
≥ College

4428
3941
4131

35.4
31.5
33.1

34.9 (1.34)
40.0 (1.35)
25.1 (1.00)

41.4 (2.2)
34.7 (2.13)
24.0 (1.55)

61.4 (4.37)
25.5 (3.87)
13.1 (2.6)

43.3 (3.63)
32.5 (3.15)
24.2 (2.45)

<.0001

Health Insurance
Yes
No

10967
1537

87.7
12.3

86.5 (0.98)
13.5 (0.98)

78.5 (1.91)
21.5 (1.91)

61.8 (4.78)
38.2 (4.78)

78.7 (3.09)
21.2 (3.10)

<.0001

Employment Status
Employed
Unemployed
Retired

5544
2568
4358

44.5
20.6
35.0

52.9 (1.35)
26.4 (1.32)
20.7 (0.84)

60.0 (2.14)
27.3 (2.06)
12.9 (1.11)

45.1 (4.60)
47.2 (4.73)
7.7 (2.3)

61.0 (3.40)
31.6 (3.40)
7.41 (1.20)

<.0001

Income
Less than $35,000
$35,00- $75,000
Greater than $75,000
DK/Refused/Missing

4523
3415
2791
1812

36.1
27.2
22.3
14.5

31.3 (1.25)
27.8 (1.16)
28.6 (1.27)
12.2 (0.89)

42.6 (2.19)
24.7 (1.75)
23.3 (1.83)
9.4 (1.37)

57.2 (4.64)
21.3 (3.79)
6.8 (1.71)
14.6 (3.72)

48.3 (3.53)
20.8 (2.42)
19.8 (2.63)
11.1 (2.32)

<.0001

177
11,673

1.4
93.3

2.86 (0.47)
97.1 (0.47)

4.21 (0.94)
95.8 (0.95)

3.49 (1.58)
96.5 (1.58)

3.97 (1.37)
87.4 (2.84)

<.0001

Participant Characteristics
Age Group (years)
18-39
40-49
50-64
≥ 65

HIV Riskc
Yes
No

HIV testing
Yes
2669
21.3
30.7 (1.28)
39.6 (2.15)
39.6 (4.56) 35.5 (3.80)
0.0031
No
8887
70.9
69.3 (1.28)
60.4 (2.15)
60.4 (4.56) 64.5 (3.38)
a
Percentages reported are weighted
b
Participants who were missing HIV testing were excluded from analysis
c
HIV Risk was assessed by measuring if the individual had engaged in any of the following behaviors that put them at risk for
HIV transmission: used intravenous drugs; received treatment for a sexually transmitted disease in the past year; received
money or drugs in exchange for sex in the past year, or had anal sex without a condom in the past year.

Table 3. Prevalence of HIV testing by sample characteristics and Reaction
to Race measures, Behavioral Risk Factor Surveillance System, Arizona &
Wyoming, 2012 a b
Participant Characteristics
Age Group (years)
18-39
40-49
50-64
≥ 65

Ever tested
% (SE)

Never tested
% (SE)

49.74 (1.77)
20.74 (1.40)
23.14 (1.37)
6.38 (0.61)

33.36 (1.22)
13.63 (0.86)
26.20 (0.94)
26.81 (0.81)

Sex
Male
Female

51.27 (1.76)
48.73 (1.76)

47.76 (1.17)
52.24 (1.17)

0.099

Race
White
Black
Hispanic

66.08 (1.88)
7.67 (1.19)
26.25 (1.78)

71.29 (1.23)
2.40 (0.39)
26.31 (1.23)

<.0001

Marital Status
Married/ Member of unmarried couple 52.45 (1.77)
Divorced/ Separated/Widowed
20.10 (1.21)
Single
27.45 (1.73)

59.28 (1.15)
20.48 (0.80)
20.24 (1.10)

0.0002

State
Arizona
Wyoming

92.08 (0.37)
7.92 (0.37)

90.1 (0.22)
9.00 (0.22)

0.043

Education Level
≤ High School
Some College
≥ College

37.80 (1.81)
36.73 (1.72)
25.48 (1.30)

42.48 (1.20)
35.46 (1.12)
22.06 (0.80)

0.038

Health Insurance
Yes
No

77.55 (1.62)
22.45 (1.62)

80.44 (1.06)
19.56 (1.06)

Employment Status
Employed
Unemployed
Retired

60.31 (1.75)
32.18 (1.73)
7.5 (0.69)

48.45 (1.17)
27.69 (1.15)
23.86 (0.77)

Income
Less than $35,000
$35,00- $75,000
Greater than $75,000
DK/Refused/Missing

41.27 (1.78)
23.90 (1.45)
25.00 (0.93)
9.62 (1.04)

37.8 (1.15)
24.99 (0.93)
21.04 (0.95)
16.20 (0.92)

P-value

<.0001

0.132

<.0001

<.0001

Table 3. Prevalence of HIV testing by sample characteristics and
Reaction to Race measures, Behavioral Risk Factor Surveillance
System, Arizona & Wyoming continued, 2012 a b
Ever tested %
Never tested
Participant Characteristics
(SE)
% (SE)
HIV Risk
Yes
6.91 (0.93)
1.43 (0.30)
No
91.97 (1.06)
97.94 (0.37)
DK/Refused/Missing
1.12 (0.55)
0.62 (0.22)

P-value

<.0001

Yes
No
DK/Refused/Missing

7.93 (1.07)
82.14 (1.41)
9.93 (1.05)

6.03 (0.71)
84.76 (0.93)
9.21 (0.69)

0.207

Yes
DK/Refused/Missing

5.28 (0.94)
10.61 (1.15)

3.31 (0.45)
9.39 (0.70)

0.054

Health care treatment
Worse
Better
DK/Refused/Missing

5.70 (0.93)
8.57 (0.91)
18.25 (1.35)

2.54 (0.40)
12.08 (0.70)
23.04 (0.970

Race Consciousness
Never
Sometimes
Always
DK/Refused/Missing

50.61 (1.77)
22.26 (1.44)
15.67 (1.52)
11.46 (1.12)

58.04 (1.18)
17.29 (0.96)
13.80 (0.96)
10.87 (0.72)

Reactions to Race Composite Score
No experiences
40.49 (1.70)
1 experience
27.96 (1.63)
≥2 experiences
7.74 (1.07)
Unknown experiences
8.93 (1.01)

45.71 (1.15)
21.30 (1.03)
5.88 (0.69)
8.09 (0.66)

<.0001

0.006

0.0004

Table 4. Unadjusted and adjusted odds ratio (95% CI) of the
relationship between sample characteristics and Reaction to Race
variables with HIV Testing, Behavioral Risk Factor Surveillance
System, Arizona & Wyoming, 2012 d e
HIV Testing
Unadjusted OR
Adjusted OR
OR
95% CI
OR
95% CI
Participant Characteristics
Race Consciousness
Never
1.00
1.00
Sometimes
1.45
(1.15-1.83)
1.26 (0.99-1.62)
Always
1.31
(0.97-1.78)
1.26 (0.87-1.82)
Emotional Symptoms
Yes
1.12
(0.73-1.75)
1.02 (0.64-1.623)
No
1.00
1.00
Physical Symptoms
Yes
1.91
(1.17-3.12)
1.82 (1.08-3.06)
No
1.00
1.00
Healthcare Treatment
Worse
2.53
(1.34-4.79)
2.09 (1.08-4.03)
Same
1.00
1.00
Better
0.68
(0.52-0.89)
0.85 (0.63-1.15)
Reactions to Race Composite Score
No experiences
1.00
1.00
1 experience
1.48
(1.20-1.83)
1.37 (1.08-1.75)
≥ 2 experiences
1.49
(1.00-2.20)
1.37 (0.90-2.08)
d
Analysis adjusted for age, race, marital status, state, income, and HIV risk
e

Odds ratios reported in the table are weighted to reflect known proportions of
age, race/ethnicity, gender, geographic region, and other known
characteristics of the population

Table 5. Descriptive characteristics all respondents of Reactions to Race Module for selected
characteristics by race/ ethnicity, Behavioral Risk Factor Surveillance System, Arizona & Wyoming,
2012
Whites
Blacks
Hispanics
P-value
(n=11007)
(n=11007)
(n=1388)
n
%
n
%
n
%
Participant Characteristics
Age Group (years)
18-39
1576
14.47
43
30.5
421
30.53
<.0001
40-49
1110
10.19
28
19.86
255
18.49
50-64
3549
32.58
38
26.95
381
27.63
≥ 65
4659
42.77
32
22.7
322
23.35
Sex
Male
Female

4482
6525

40.72
59.28

73
73

50
50

549
839

39.55
60.45

0.05

Marital Status
Married/ Member of unmarried couple
Divorced/ Separated/Widowed
Single

6385
3528
1027

58.36
32.25
9.39

59
52
35

40.41
35.62
23.97

736
394
250

53.33
28.55
18.12

<.0001

5320
5687

48.33
51.67

125
21

85.62
14.38

1139
249

82.06
17.94

<.0001

Education Level
≤ High School
Some College
≥ College

3529
3558
3889

32.15
32.42
35.43

51
47
46

35.42
32.64
31.94

848
336
196

61.45
24.35
14.2

<.0001

Health Insurance
Yes
No

9869
1106

89.92
10.08

118
28

80.82
19.18

980
403

70.86
29.14

<.0001

Employment Status
Employed
Unemployed
Retired

4808
2058
4086

43.9
18.79
37.31

76
39
30

52.41
26.9
20.69

660
471
242

48.07
34.3
17.63

<.0001

Income
Less than $35,000
$35,00- $75,000
Greater than $75,000
DK/Refused/Missing

3684
3116
2618
1589

33.47
28.31
23.78
14.44

74
34
25
13

50.68
23.29
17.12
8.9

765
265
148
210

55.12
19.09
10.66
15.13

State
Arizona
Wyoming

<.0001

Table 5. Descriptive characteristics all respondents of Reactions to Race Module for selected
characteristics by race/ ethnicity, Behavioral Risk Factor Surveillance System, Arizona & Wyoming,
continued 2012
Whites
Blacks
Hispanics
P-value
(n=11007)
(n=11007)
(n=1388)
n
%
n
%
n
%
Participant Characteristics
HIV Risk
Yes
135
1.23
7
4.79
35
2.52
<.0001
No
10308
93.65
132
90.41
1233
88.83
DK/Refused/Missing
564
5.12
7
4.79
120
8.65
Emotional Symptoms
Yes
No
DK/Refused/Missing

243
9784
980

2.21
88.89
8.9

20
110
16

13.7
75.34
10.96

135
1054
199

9.73
75.94
14.34

Physical Symptoms
Yes
No
DK/Refused/Missing

150
9886
971

1.36
89.92
8.82

8
119
19

5.48
81.51
13.01

95
1089
204

6.84
78.46
14.7

Healthcare Treatment
Worse
Same
Better
DK/Refused/Missing

210
6846
1256
2695

1.91
62.2
11.41
24.48

10
88
13
36

6.85
60.27
8.9
23.97

55
840
164
329

3.96
60.52
11.82
23.7

Race Consciousness
Never
Sometimes
Always
DK/Refused/Missing

7917
1470
405
1215

71.93
13.36
3.68
11.04

50
74
125
146

34.25
16.44
34.93
14.38

509
241
398
240

36.67
17.36
28.67
17.29

Reactions to Race Composite Score
No experiences
1 experience
≥2 experiences
Unknown experiences

6161
1501
210
877

70.42
17.16
2.4
10.02

37
43
21
15

31.9
37.07
18.1
12.93

395
456
128
181

34.05
39.31
11.03
15.6

HIV Testing
Ever tested
Never tested
DK/Missing

2232
7935
840

20.28
72.09
7.63

70
65
11

47.95
44.52
7.53

367
887
134

26.44
63.9
9.65

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001

Table 6. Prevalence and odds ratio (95% Confidence Intervals) of HIV testing by sample characteristics and Reaction to Race measures by race/
ethnicity, Behavioral Risk Factor Surveillance System, Arizona & Wyoming, 2012 f g
Whites
Blacks
Ever
Never
Ever
Never
tested tested
tested
tested
Particpant characterisitcs
%
%
OR
95% CI
%
%
OR
Overall prevalence
31.64 68.36
61.52
38.48
Emotional Symptoms
Yes
No
DK/Refused/Missing

4.64
85.40
9.96

2.48
88.24
9.27

0.78
1.00

(0.35-1.70)

Physical Symptoms
Yes
No
DK/Refused/Missing

2.67
87.58
9.75

1.34
89.30
9.36

1.72
1.00

Healthcare Treatment
Worse
Same
Better
DK/Refused/Missing

4.50
68.95
8.89
17.66

2.29
62.23
11.93
23.54

2.03
1.00
0.73

Race Consciousness
Never
Sometimes
Always
DK/Refused/Missing

59.76
23.26
5.82
11.16

69.07
15.64
4.49
10.81

1.00
1.01
1.01

Reactions to Race Composite Score
No experiences
57.21
1 experience
27.51
≥2 experiences
4.94
Unknown experiences
10.34

66.74
19.65
3.27
10.33

1.00
1.37
1.74

f

95% CI

Ever
tested
%
33.25

Hispanics
Never
tested
%
OR
66.75

13.29
76.84
9.87

14.77
76.16
9.07

18.04
72.14
9.83

15.84
75.44
8.71

0.99
1.00

(0.13-7.91)

(0.77-3.84)

11.69
76.32
11.99

7.02
81.97
11.00

8.23
1.00

(1.58-42.7)

10.00
77.66
12.34

(0.61-6.72)

16.92
55.14
9.58
18.36

3.33
55.62
13.37
27.68

13.90
1.00
2.27

(2.06-94.3)

(0.55-1.84)
(0.56-1.81)

34.21
13.46
39.04
13.29

37.40
13.93
41.97
6.70

1.00
1.72
2.52

(1.07-2.83)
(1.06-1.78)

32.24
33.12
23.09
11.54

40.60
30.04
20.67
8.68

1.00
2.57
2.50

(0.35-1.54)

95% CI

0.83
1.00

(0.40-1.72)

8.31
82.38
9.31

1.75
1.00

(0.82-3.75)

5.46
67.36
7.48
19.71

3.12
63.27
12.37
21.24

1.99
1.00
0.76

(0.61-6.50)

(0.14-21.4)
(0.46-13.8)

32.35
22.31
33.63
11.70

30.02
22.08
36.47
11.44

1.00
1.01
1.01

(0.55-1.86)
(0.57-1.79)

(0.36-18.3)
(0.29-21.3)

26.76
46.83
15.81
10.58

29.83
44.03
16.95
9.19

1.00
1.30
1.10

(0.76-2.21)
(0.52-2.30)

(0.50-10.2)

(0.37-1.58)

All analysis adjusted for age, and marital status. The model for Whites was additionally adjusted for sex, education level, health insurance, employment, HIV risk and
income. The model for Blacks was additionally adjusted for employment status. The model for Hispanics was additionally adjusted for sex and HIV risk.
g
Odds ratios reported in the table are weighted samples to reflect known proportions of age, race/ethnicity, gender, geographic region, and other known
characteristics of the population

Appendix 1. Comparison of descriptive statistics of participants not tested in the past year and participants never tested for HIV, Behavioral Risk Factor
Surveillance System, Arizona & Wyoming, 2012
HIV Testing
Tested in the Not tested in
Ever HIV Never tested for
Not tested in Never tested
past year %
past year % P-value testing %
HIV %
P-value past year %
for HIV%
P-value
Participant Characteristics
Age Group (years)
18-39
73.81
46.03
52.76
33.36
46.03
33.36
<.0001
<.0001
<.0001
40-49
11.4
24.43
21.27
13.63
24.42
13.62
50-64
11.25
24.19
21.05
26.2
24.19
26.2
≥ 65
3.55
5.35
4.62
26.81
5.35
26.81

Sex
Male
Female

58.73
41.27

49.45
50.55

Race
White
Black
Hispanic

61.48
11.5
57.02

66.47
7.45
26.09

Marital Status
Married/ Member of unmarried couple
Divorced/ Separated
Widowed
Single

37.21
18.75
0.992
43.08

55.93
17.59
1.95
24.53

State
Arizona
Wyoming

93.53
6.47

91.51
8.49

Education Level
≤ High School
Some College
≥ College

36.17
40.06
23.79

36.83
36.59
26.58

Health Insurance
Yes
No

74.92
25.08

78.31
21.69

0.038

0.328

<.0001

0.072

0.656

0.407

51.71
48.29

47.76
52.24

65.25
8.44
26.31

71.29
2.4
26.21

51.4
17.86
1.72
29.02

59.28
12.4
8.08
20.24

92
8

91
9

36.67
37.44
25.89

42.48
35.46
22.06

77.49
22.51

80.43
19.56

0.078

<.0001

<.0001

0.077

0.015

0.142

49.45
50.55

47.76
52.24

66.47
7.45
26.09

71.29
2.4
26.31

55.93
17.59
1.95
24.53

59.28
12.4
8.08
20.24

91.51
8.49

91
9

36.83
36.59
26.58

42.48
35.46
22.06

78.31
21.69

80.44
19.56

0.496

<.0001

<.0001

0.42

0.025

0.336

Appendix 1. Comparison of descriptive statistics of participants not tested in the past year and participants never tested for HIV, Behavioral Risk
Factor Surveillance System, Arizona & Wyoming, 2012 continued
HIV Testing
Tested in the past
year %

Not tested in past
year %

Employment Status
Employed
Unemployed
Retired

61.56
34.69
3.75

62.55
31.02
6.44

Income
Less than $35,000
$35,00- $75,000
Greater than $75,000
DK/Refused/Missing

51.01
23.87
17.36
7.76

38.66
24.88
27.52
8.95

HIV Risk
Yes
No

12.24
86.4

5.72
93.47

Emotional Symptoms
Yes
No
DK/Refused/Missing

9.26
77.05
13.69

6.9
84.08
9.02

Physical Symptoms
Yes
No
DK/Refused/Missing

5.36
81.01
13.62

5.05
84.87
10.09

Healthcare Treatment
Worse
Same
Better
DK/Refused/Missing

6.36
64.02
9.97
19.65

5.71
69.37
7.66
17.25

P-value

Ever HIV testing Never tested for
Not tested in Never tested for
%
HIV %
P-value past year %
HIV%
P-value

Participant Characteristics
0.261

0.02

0.088

0.144

0.538

0.618

62.31
31.91
5.78

48.45
27.69
23.5

41.67
24.63
25.04
8.66

37.75
25
21.04
16.2

7.3
91.74

1.44
97.94

7.47
82.37
10.16

6.03
82.37
9.21

5.12
83.93
10.95

3.3
87.31
9.38

5.87
68.07
8.22
17.84

2.54
62.35
12.08
23.04

<.0001

<.0001

<.0001

0.367

0.077

<.0001

62.55
31.02
6.44

48.45
27.69
23.86

38.66
24.88
27.52
8.94

37.75
25
21.04
16.2

5.72
93.47

1.44
97.94

6.9
84.08
9.02

6.03
84.76
9.2

5.05
84.87
10.09

3.31
87.31
9.38

5.71
69.37
7.66
17.25

2.54
62.37
12.08
23.04

<.0001

<.0001

0.0002

0.218

0.206

<.0001

Appendix 1. Comparison of descriptive statistics of participants not tested in the past year and participants never tested for HIV, Behavioral Risk
Factor Surveillance System, Arizona & Wyoming, 2012 continued
HIV Testing
Tested in the past
year %

Not tested in past
year %

Participant Characteristics
Race Consciousness
Never
Sometimes
Always
DK/Refused/Missing

13.56
22.79
48.556
15.09

15.49
23.96
50.53
10.02

Reactions to Race Composite
Score
No experiences
1 experience
≥2 experiences
Unknown experiences

45.04
32.68
8.79
13.49

47.37
34.23
8.76
9.65

P-value

0.383

0.677

Ever HIV testing Never tested for
Not tested in Never tested for
%
HIV %
P-value past year %
HIV%
P-value

15.02
23.68
50.05
11.25

13.8
17.29
58.04
10.87

46.81
33.85
8.76
10.58

56.44
26.3
7.27
9.99

0.002

0.002

15.49
23.96
50.53
10.02

13.8
17.29
58.04
10.87

47.37
34.23
8.76
9.65

56.44
26.3
7.27
9.99

0.005

0.007

